Nous-PEV

· Nouscom SRL

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nous-PEV, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma [Phase 1]